Description
An allosteric P2Y1 receptor antagonist (Ki = 6 nM for the human receptor); selective for P2Y1 over P2Y2, P2Y6, P2Y11, P2Y12, and P2Y14 receptors with (Kis = ≥3,500 nM); inhibits platelet aggregation in hPRP (IC50 = 2.1 µM); reduces thrombus weight by 68% in a rat model of iron chloride-induced arterial thrombosis and prolongs provoked cuticle and mesenteric bleeding time in rats at a 10 mg/kg bolus dose followed by a 10 mg/kg per hour infusion; inhibits contractions induced by electrical field stimulation in isolated muscle strips from rat and mouse colon (EC50s = 0.5 and 0.1 µM, respectively) and antrum (EC50s = 9 and 0.3 µM, respectively)
Formal name: N-[2-[2-(1,1-dimethylethyl)phenoxy]-3-pyridinyl]-N’-[4-(trifluoromethoxy)phenyl]-urea
Synonyms:
Molecular weight: 445.4
CAS: 870544-59-5
Purity: ≥98%
Formulation: A solid